For the year ending 2025-12-31, FBIOP has $185,548K in assets. $123,365K in debts. $79,381K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 79,381 | |||
| Accounts receivable, net | 29,783 | |||
| Inventory | 9,624 | |||
| Other receivables | 158 | |||
| Prepaid expenses and other current assets | 4,895 | |||
| Assets held for sale | 0 | |||
| Total current assets | 123,841 | |||
| Property, plant and equipment, net | 2,519 | |||
| Operating lease right-of-use asset, net | 12,302 | |||
| Restricted cash | 1,220 | |||
| Equity investments, at fair value | 17,660 | |||
| Intangible assets, net | 27,605 | |||
| Other assets | 401 | |||
| Total assets | 185,548 | |||
| Accounts payable and accrued expenses | 47,125 | |||
| Income taxes payable | 356 | |||
| Common stock warrant liabilities | 1 | |||
| Operating lease liabilities, short-term | 2,127 | |||
| Partner company installment payments - licenses, short-term | 0 | |||
| Other current liabilities | 135 | |||
| Total current liabilities | 49,744 | |||
| Notes payable, long-term, net | 52,417 | |||
| Operating lease liabilities, long-term | 12,672 | |||
| Partner company redeemable perpetual preferred liability | 7,085 | |||
| Other long-term liabilities | 1,447 | |||
| Total liabilities | 123,365 | |||
| Cumulative redeemable perpetual preferred stock, 0.001 par value, 15,000,000 authorized, 5,000,000 designated series a shares, 3,427,138 shares issued and outstanding as of december 31, 2025 and december 31, 2024, respectively, liquidation value of 25.00 per share | 3 | |||
| Common stock, 0.001 par value, 200,000,000 shares authorized, 31,364,094 and 27,908,839 shares issued and outstanding as of december 31, 2025 and december 31, 2024, respectively | 31 | |||
| Additional paid-in-capital | 783,891 | |||
| Accumulated deficit | -734,052 | |||
| Total stockholders' equity attributed to the company | 49,873 | |||
| Non-controlling interests | 12,310 | |||
| Total stockholders' equity (deficit) | 62,183 | |||
| Total liabilities and stockholders' equity (deficit) | 185,548 | |||
Fortress Biotech, Inc. (FBIOP)
Fortress Biotech, Inc. (FBIOP)